Dear Members, please see below the notification from MedTech Europe regarding EU RoHS (but also impacting UK RoHS, as these assessments were kicked off prior to BREXIT). The Umbrella Project coordinates and submits applications for RoHS exemption packs when there is a more general and not specific sectorial exemptions.
The main issues are: need for clarification of whether new applications for exemption pack renewals should be submitted, considering the significant delays there have been with reviewing the current exemption pack renewals. In addition they have asked for clarification of when a decision will be made on the current exemption pack renewal requests.
They have also highlighted that the ongoing uncertainty regarding the current delays and future timelines means that industry is finding it difficult to plan, especially where the renewal decision (or not) goes beyond the exemption pack renewal date meaning that a decision not to renew could leave the sector facing a cliff edge:
Dear members,
I hope you are all well.
With this e-mail, we would like to share with you a letter that was sent by the Chairs of the RoHS Umbrella Project to the European Commission regarding the timelines for the exemption renewal requests in Annex III Packs 22, 23 & 24.
Following a call of the Umbrella Project last week, a letter was sent, the main point addressed is the need for clarity as to when the draft delegated acts will be issued by the Commission, as this will to a large extent determine if/when renewals for those exemptions need to be prepared and submitted by the Umbrella Project. This is a process that takes time, robust data needs to be gathered and coordinated with the 70+ stakeholders in the Umbrella Project.
As MedTech Europe, we are aware that this is an issue for many members and we will continue to work closely with the Umbrella Project on this.
As soon as we have more news, we will inform members.
